The PimaPak product line: five more products, graded by evidence

The clinic's research folder holds nine product files. Four of them — EDTA, DMSO, chlorine dioxide and lumbrokinase — are already assessed on the condition pages and in the readings above. The other five were left for an owner decision; the owner has asked for them to be covered within the same rule: what the independent sources say, graded, with the passage beside each statement. None of this is a recommendation for or against a product.

MSM (methylsulfonylmethane) — hypothesis with a reasonable safety record

A 2017 review of the supplement reports that, as a Generally Recognized As Safe (GRAS) approved substance, MSM is well-tolerated by most individuals at dosages of up to four grams daily, with few known and mild side effects.¹ On benefit the same review is cautious: initial evidence is available regarding the dose of MSM needed to provide benefit, although additional work is underway to determine the precise dose and time course of treatment needed to provide optimal benefits.² A product sold for joint pain on that basis is selling a plausible but unsettled claim.

IP-6 (inositol hexaphosphate) — hypothesis

Memorial Sloan Kettering's herb reference puts it in one line: lab studies have shown anticancer effects, but clinical data are lacking.³ The one human signal is small: small studies of breast cancer patients showed that IP6 may be effective in reducing chemotherapy-associated side effects. Larger studies are needed.⁴ The same reference lists "evidence is lacking" for heart disease, depression and kidney stones, and notes that phytic acid can bind minerals such as calcium, iron, magnesium and zinc.

Beta-glucan — established for one narrow claim, as food

The only authorised health claim is a food claim, not a supplement claim. The regulation allows a label to say that diets low in saturated fat and cholesterol that include a stated amount of soluble fiber per day from oats, barley or psyllium may reduce the risk of heart disease.⁵ That is about soluble fibre in a diet. Immune, cancer or "detox" claims for beta-glucan capsules are not part of that record and sit at hypothesis level.

Kalanchoe pinnata — hypothesis, with a safety flag

A 2026 review in Molecules concludes that current evidence supports the biological activity of several Kalanchoe pinnata extracts and isolated constituents under experimental conditions, but the extent to which these findings translate into clinically relevant therapeutic effects remains uncertain.⁶ The limited number of human studies, substantial variability in extract composition, incomplete pharmacokinetic characterization, and safety concerns related particularly to bufadienolides currently restrict broader clinical interpretation.⁷ Bufadienolides are cardiac glycosides, the same family as digitalis; a plant extract whose dose of them is unknown is not a safe home remedy.

Borax (sodium borate) — not a supplement; documented harm

Borax is a cleaning product and pesticide. The NIH fact sheet on boron is direct: boron can cause harm if a person accidentally swallows cleaning products or pesticides that contain certain forms of boron, such as borax (sodium borate) or boric acid.⁸ Very high amounts of boron can cause death.⁹ The adult upper limit for boron from all sources is 20 mg a day, and boron is not known to interact or interfere with any medicines or dietary supplements¹⁰ — which is a statement about boron in food and supplements, not a licence to swallow borax. Anyone who has swallowed borax should call Poison Control at 1-800-222-1222.

What this means for a reader

Two of the five rest on a reasonable safety record and an unsettled benefit (MSM, beta-glucan as food); two rest on laboratory findings with little human evidence (IP-6, Kalanchoe), one of them carrying a cardiac-glycoside safety concern; and one is a household chemical that the evidence says not to swallow (borax). Bring any of these to your pharmacist before taking them alongside prescribed medicines.